The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat
- PMID: 16648369
- DOI: 10.1124/jpet.106.102905
The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat
Abstract
"Dopamine stabilizers" are a new class of compounds that have the ability to reverse both hypo- as well as hyperdopaminergia in vivo. This class, exemplified by the phenylpiperidines (S)-(-)-3-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonyl-phenyl)-1-propyl)-piperidine [ACR16] although lacking high in vitro binding affinity for dopamine D2 receptor [(-)-OSU6162, Ki = 447 nM; ACR16, Ki > 1 microM], shows functional actions, suggestive of their interaction. Hence, we evaluated in vivo D2 occupancy of these agents in rats and correlated it to observed effects in a series of behavioral, neurochemical, and endocrine models relevant to the dopamine system and antipsychotic effect. Both (-)-OSU6162 and ACR16 showed robust dose-dependent striatal D2 occupancy with ED50 values of 5.27 and 18.99 mg/kg s.c., respectively, and functional assays showed no partial agonism. Over an occupancy range of 37 to 87% (3-60 mg/kg) for (-)-OSU6162 and 35 to 74% (10-60 mg/kg) for ACR16, we observed both inhibitory (amphetamine-induced locomotor activity) and stimulatory effects (in habituated rats). Haloperidol, over a similar occupancy range (33-78%), potently inhibited psychostimulant activity and induced catalepsy, but it failed to activate habituated animals. In the conditioned avoidance response assay, ACR16 was clearly more efficacious than (-)-OSU6162. In addition, both these compounds demonstrated significant preferential Fos induction in the nucleus accumbens compared with the dorsolateral striatum, a strong predictor of atypical antipsychotic efficacy. The results suggest that dopamine stabilizers exhibit locomotor stabilizing as well as antipsychotic-like effects, with low motor side effect liability, in a dose range that corresponds to high D2 in vivo occupancy.
Similar articles
-
Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.Naunyn Schmiedebergs Arch Pharmacol. 2011 Jul;384(1):39-45. doi: 10.1007/s00210-011-0641-y. Epub 2011 May 2. Naunyn Schmiedebergs Arch Pharmacol. 2011. PMID: 21533991
-
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.Neuropsychopharmacology. 2006 Sep;31(9):1854-63. doi: 10.1038/sj.npp.1300983. Epub 2005 Nov 30. Neuropsychopharmacology. 2006. PMID: 16319908
-
Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization.J Neural Transm (Vienna). 2008 Jun;115(6):899-908. doi: 10.1007/s00702-008-0038-3. Epub 2008 Mar 20. J Neural Transm (Vienna). 2008. PMID: 18351286
-
The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties.Eur J Pharmacol. 2010 Feb 25;628(1-3):19-26. doi: 10.1016/j.ejphar.2009.11.025. Epub 2009 Nov 15. Eur J Pharmacol. 2010. PMID: 19919834
-
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.Mol Psychiatry. 1998 Mar;3(2):123-34. doi: 10.1038/sj.mp.4000336. Mol Psychiatry. 1998. PMID: 9577836 Review.
Cited by
-
II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors.J Neural Transm (Vienna). 2011 Nov;118(11):1523-33. doi: 10.1007/s00702-011-0701-y. Epub 2011 Aug 25. J Neural Transm (Vienna). 2011. PMID: 21866391
-
Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.Br J Clin Pharmacol. 2017 Oct;83(10):2214-2224. doi: 10.1111/bcp.13317. Epub 2017 Jun 21. Br J Clin Pharmacol. 2017. PMID: 28449367 Free PMC article.
-
Effects of the monoamine stabilizer, (-)-OSU6162, on cocaine-induced locomotion and conditioned place preference in mice.Naunyn Schmiedebergs Arch Pharmacol. 2021 Jun;394(6):1143-1152. doi: 10.1007/s00210-021-02053-x. Epub 2021 Jan 20. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33471153
-
Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.Naunyn Schmiedebergs Arch Pharmacol. 2011 Jul;384(1):39-45. doi: 10.1007/s00210-011-0641-y. Epub 2011 May 2. Naunyn Schmiedebergs Arch Pharmacol. 2011. PMID: 21533991
-
The monoamine stabilizer (-)-OSU6162 prevents the alcohol deprivation effect and improves motor impulsive behavior in rats.Addict Biol. 2019 May;24(3):471-484. doi: 10.1111/adb.12613. Epub 2018 Feb 26. Addict Biol. 2019. PMID: 29480646 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources